Top Point Of Care Diagnostics Companies

Point Of Care Diagnostics Market size was valued at USD 50.54 Billion in 2023 and is poised to grow from USD 53.62 Billion in 2024 to USD 86.12 Billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

'Abbott Laboratories (US)   ', ' Siemens Healthineers AG (Germany)   ', ' Quidel Corporation (US)   ', ' F. Hoffman-La Roche Ltd. (Switzerland)   ', ' Danaher Corporation (US)   ', ' Becton, Dickinson and Company (US)   ', ' Chembio Diagnostics (US)   ', ' EKF Diagnostics (UK)   ', ' Trinity Biotech plc (Ireland)   ', ' Instrumentation Laboratory (US)   ', ' Nova Biomedical (US)   ', ' PTS Diagnostics (US)   ', ' Sekisui Diagnostics (US)  '

• It has become easy to improve the efficiency and accuracy of POCT devices with the help of miniaturization of sensors, development of novel detection methods such as biosensors and microfluidics, and integration of wireless connectivity. Moreover, advancements in materials science and manufacturing techniques allow the production of affordable and efficient POC diagnostics solutions. 

• The shift towards personalized and targeted therapies presents a significant potential for point-of-care diagnostics. These tools are essential for delivering swift and tailored diagnostic results, enabling healthcare providers to customize treatment strategies based on the unique profiles of individual patients.  

North America is dominating the global point of care diagnostics market as it did in the previous revenue period. The rising of geriatric population and the presence of better medical facilities are contributing to the market share. Furthermore, technological advancements like the launch of miniaturized diagnostic equipment providing precise and rapid results are propelling the market growth. The rising market penetration of Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMRs) are also increasing the demand of point of care diagnostics market in the region. Moreover, the presence of prominent players like Abbott, BIOMERIEUX, BD, Siemens Healthineers AG, QIAGEN, Quidel Corporation, and Quest Diagnostics is positively influencing market growth.